It looks like Actemra by Roche, another anti-IL6 mab, also undergoing trial. Since Regeneron and Roche are much bigger than us, Fauci could be referring to them.
Patterson did mention that he believes that Leronlimab modulates IL-6, TNF and T suppressor so the clinical response maybe more powerful than drugs just targeting one of these molecules. This is where Ohm maybe able to do more DD for us.
Patterson did mention that he believes that Leronlimab modulates IL-6, TNF and T suppressor so the clinical response maybe more powerful than drugs just targeting one of these molecules. This is where Ohm maybe able to do more DD for us.